Vulnerability · CVE-2025-12952
A privilege escalation vulnerability exists in Google Cloud's Dialogflow CX.
Published Dec 10, 2025 · catalog updated Oct 14, 2026 · A privilege escalation vulnerability
Check if you run it
No confirmed exploitation is on record for CVE-2025-12952. EPSS is 0.37%. Act only if a listed version of A privilege escalation vulnerability is installed.
Gaps on this record
- The stored product name is a package slug. The name on this page is taken from the title (A privilege escalation vulnerability).
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- High8.7
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.37%
- Remediation
- Not established
- Affected products
- See sources for product scope
A privilege escalation vulnerability exists in Google Cloud's Dialogflow CX. Dialogflow agent developers with Webhook editor permission are able to configure Webhooks using Dialogflow service agent access token authentication. This allows the attacker to escalate their privileges from agent-level to project-level, granting them unauthorized access to manage resources in services associated with the project, leading to unexpected costs and resource depletion for the producer project. A fix was applied on the server side to protect from this vulnerability in February 2025. No customer action is required.
No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.
How to fix CVE-2025-12952
Recommended remediation
No required-action text, fix commit, or clear fixed-version range is stored yet.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2025-12952. EPSS is 0.37%. Act only if a listed version of A privilege escalation vulnerability is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-269: Improper Privilege Management. EPSS 0.37%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Dec 10, 2025 · NIST NVD
Detected
A privilege escalation vulnerability exists in Google Cloud's Dialogflow CX. Dialogflow agent developers with Webhook editor permission are able to configure Webhooks using Dialogflow service agent access token authentication. This allows the attacker to escalate their privileges from agent-level to project-level, granting them unauthorized access to manage resources in services associated with th
Oct 14, 2026 · NIST NVD
Updated
A privilege escalation vulnerability exists in Google Cloud's Dialogflow CX. Dialogflow agent developers with Webhook editor permission are able to configure Webhooks using Dialogflow service agent access token authentication. This allows the attacker to escalate their privileges from agent-level to project-level, granting them unauthorized access to manage resources in services associated with th
Sources
- CVE.orgVulnerability recordCVE-2025-12952
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2025-12952
30-day exploitation probability 0.4%
first.org - NIST NVDVulnerability recordCVE-2025-12952
A privilege escalation vulnerability exists in Google Cloud's Dialogflow CX. Dialogflow agent developers with Webhook editor permission are able to configure Webhooks using Dialogflow service agent access token authentication. This allows the attacker to escalate their privileg
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 16, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.